From the Food and Drug Administration

JAMA. 2000 May 3;283(17):2228.
No abstract available

MeSH terms

  • Anti-Infective Agents, Local*
  • Bacterial Vaccines*
  • Bandages*
  • Chromans* / adverse effects
  • Cisapride* / adverse effects
  • Drug Approval
  • Drug and Narcotic Control
  • Equipment Contamination*
  • Gastrointestinal Agents* / adverse effects
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Humans
  • Hypoglycemic Agents* / adverse effects
  • Infant
  • Meningococcal Vaccines*
  • Pneumococcal Vaccines*
  • Streptococcus pneumoniae*
  • Thiazoles* / adverse effects
  • Thiazolidinediones*
  • Troglitazone
  • United States
  • United States Food and Drug Administration
  • Vaccines, Conjugate*

Substances

  • Anti-Infective Agents, Local
  • Bacterial Vaccines
  • Chromans
  • Gastrointestinal Agents
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Hypoglycemic Agents
  • Meningococcal Vaccines
  • Pneumococcal Vaccines
  • Thiazoles
  • Thiazolidinediones
  • Vaccines, Conjugate
  • Troglitazone
  • Cisapride